<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220625055275N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-15</date_registration>
      <primary_sponsor>Ardabil University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of direct current transcranial stimulation (tDCS) on the improvement of the attention network</public_title>
      <acronym></acronym>
      <scientific_title>Behavioral and electrophysiological study of the effectiveness of direct current transcranial stimulation (tDCS) on the improvement of the attention network in tinnitus sufferes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-06-27</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64419</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Factorial, Purpose: Supportive, Randomization description: To group the subjects, we will do the following steps:
Step 1: We set the values of F and M equal to the number of women and men, respectively (F and M will be at least 15).
Step 2: We assign numbers 1 to F to each of the female subjects and numbers 1 to M to the male subjects.
Step 3: We execute the command sample(1:F,7) in R statistical software.
This command will result in 7 people (approximately 50% of the 15 female subjects) being randomly selected.
Step 4: We execute the sample(1:M,8) command in R statistical software.
This command will result in 8 people (approximately 50% of the 15 male subjects) being randomly selected.
Step 5: Men and women whose numbers are extracted in step 3 and step 4 will be included in the experimental group.
Step 6: The remaining 8 women and 7 men will be in the control group.
Note: It should be noted that if, after this grouping, the age was heterogeneous between the two experimental and control groups, the age variable can be entered as an co-variate in the MANCOVA model, Blinding description: In each clinical trial design, three groups can influence the results of the study. Experiments, researcher, evaluator or analyst. In this study, by randomly selecting participants in two experimental and control groups and applying independent variables to both groups, which are in one sham and play the role of placebo.
Also, the analyst is not aware of the sham of the intervention in the group and they become practically blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Attention network.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Transcranial direct current stimulation (tDCS) in this study, this treatment method will be provided during 10 sessions and 3 sessions per week. In each session for 20 minutes, the current intensity of 2 mA will be applied to the participants in the experimental group. Intervention 2: Control group: Control group: transcranial direct current stimulation (tDCS) in this study, this treatment method will be provided during 10 sessions and 3 sessions per week. In each session, for 30 seconds, the current intensity of 2 mA will be applied to the control (sham) group.Control group: transcranial direct current stimulation (tDCS) in this study, this treatment method will be provided during 10 sessions and 3 sessions per week. In each session, for 30 seconds, the current intensity of 2 mA will be applied to the control (sham) group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information. I will publish it if necessary</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Mansour Bayrami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Building No. 2, Faculty of Educational Sciences and Psychology,Tabriz University29 Bahman Blvd,Tabriz,</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166616471</zip>
        <telephone>+98 41 3339 2116</telephone>
        <email>Dr.bayrami@yahoo.com</email>
        <affiliation>The University of Tabriz</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Masoor Bayrami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Building No. 2, Faculty of Educational Sciences and Psychology,Tabriz University29 Bahman Blvd,Tabriz,Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166616471</zip>
        <telephone>+98 41 3339 2133</telephone>
        <email>Dr.bayrami@yahoo.com</email>
        <affiliation>The University of Tabriz</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being right-handed
Being in the age range of 18-55 years
Chronic tinnitus for more than six months
Achieve a score of more than 58 in the tinnitus disability questionnaire
Having normal hearing
, Having normal or corrected vision
Complete the consent form to participate in the training program
Lack of acute psychological problems (based on the individual's own opinion and the researcher's interview)
Lack of a history of obvious neurological and cognitive diseases and head trauma</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Therapeutic intervention with the help of other methods during the research
History of seizures, brain tumors, strokes and bleeding
Having substance abuse
Left-handedness or absence of a dominant hand
Not being in the age range of 18-55
No tinnitus or tinnitus for less than six months
Obtaining a score less than 58 in the tinnitus disability questionnaire
Having a hearing loss
Having an uncorrected vision problem</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Transcranial direct current stimulation (tDCS) in this study, this treatment method will be provided during 10 sessions and 3 sessions per week. In each session for 20 minutes, the current intensity of 2 mA will be applied to the participants in the experimental group.</i_keyword>
      <i_keyword>Control group: Control group: transcranial direct current stimulation (tDCS) in this study, this treatment method will be provided during 10 sessions and 3 sessions per week. In each session, for 30 seconds, the current intensity of 2 mA will be applied to the control (sham) group.Control group: transcranial direct current stimulation (tDCS) in this study, this treatment method will be provided during 10 sessions and 3 sessions per week. In each session, for 30 seconds, the current intensity of 2 mA will be applied to the control (sham) group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Attention network alerting component:in the behavioral test, a cross (+) is displayed in the center of the screen, with flankers in the form of congruent (&lt;&lt;&lt;&lt;&lt;) or incongruent (&gt;&gt;&gt;&gt;&lt;&gt;&gt;&gt;&gt;) above or below it appear. Participants are required to focus on the cross during the test period and when the flankers appear, with high speed and accuracy in the direction of the central arrow using the mouse (the left mouse key for when the central arrow tip is to the left and the key the right side of the mouse when the tip of the central arrow is to the right). The alert component is obtained from the fraction of the reaction time and the number of errors of the central sign from the alarm without a sign. Timepoint: After randomization into two experimental and control groups, the pre-test is performed, then the intervention is carried out in 10 sessions and transcranial stimulation is applied in 3 sessions every week for 20 beats, then the post-test is performed. Method of measurement: Attention network test, quantitative electroencephalography.</prim_outcome>
      <prim_outcome>Orientation component of the attention network: the orientation component is obtained from the fraction of the reaction time and the number of spatial cue errors from the central cue. Timepoint: After randomization into two experimental and control groups, the pre-test is performed, then the intervention is carried out in 10 sessions and transcranial stimulation is applied in 3 sessions every week for 20 beats, then the post-test is performed. Method of measurement: Attention network test, quantitative electroencephalography.</prim_outcome>
      <prim_outcome>Executive component of attention network:The executive control component is obtained from the fraction of the reaction time and the number of errors of the incongruent arrows from the congruent ones. Timepoint: After randomization into two experimental and control groups, the pre-test is performed, then the intervention is carried out in 10 sessions and transcranial stimulation is applied in 3 sessions every week for 20 beats, then the post-test is performed. Method of measurement: Attention network test, quantitative electroencephalography.</prim_outcome>
      <prim_outcome>The absolute power of the alpha wave in the frontal region. Timepoint: After randomization into two experimental and control groups, the pre-test is performed, then the intervention is carried out in 10 sessions and transcranial stimulation is applied in 3 sessions every week for 20 beats, then the post-test is performed. Method of measurement: Quantitative electroencephalography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Improvement of attention after intervention based on Tinnitus Disability Questionnaire score. Timepoint: Before and after intervention sessions. Method of measurement: 25-question tinnitus disability questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>I have no sponsorship or financial prohibition from an institution or organization</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-31</approval_date>
        <contact_name>Research Ethics Committees of university of Tabriz</contact_name>
        <contact_address>29 Bahman Boulevard, Tabriz University, Central Library and University Document Center, Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
